AC8 0.00% 4.0¢ auscann group holdings ltd

Ann: AusCann Releases Low-dose Form Capsule, page-7

  1. 1,036 Posts.
    lightbulb Created with Sketch. 239
    The dont need to do Clinical Trials they already meet TGA/FDA guidelines.

    The IP companies need to do the Clinical Trials like Zelira and Insomnia which is due tomorrow..

    Then the Hard Cap can be used as the delivery method.

    Interesting this announcement dropped before Insomnia!
 
watchlist Created with Sketch. Add AC8 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.